带回家纳洛酮培训前后的注射吸毒频率
该队列研究利用墨尔本注射吸毒者队列(SuperMIX)2008至2021年的前瞻性自我报告行为数据,纳入189名在接受带回家纳洛酮(THN)培训前已有注射频率数据的注射吸毒者,采用固定效应广义线性(泊松)多水平模型分析培训前后注射频率等指标的变化。结果显示,培训后注射频率(IRR 0.91,95%CI 0.69-1.20,P=0.51)、阿片类注射频率(IRR 0.95,95%CI 0.74-1.23,P=0.71)、苯二氮䓬类使用频率(IRR 0.96,95%CI 0.69-1.33,P=0.80)及独自用药时间比例(IRR 1.04,95%CI 0.86-1.26,P=0.67)均无显著变化。作者认为,不应因担心风险补偿而拒绝提供THN培训,并需倡导THN的可及性和使用以应对前所未有的阿片类相关死亡。
要点
- 在189名注射吸毒者中,THN培训后注射频率无显著变化(IRR 0.91,95%CI 0.69-1.20,P=0.51)。
- 阿片类注射频率(IRR 0.95,95%CI 0.74-1.23,P=0.71)和苯二氮䓬类使用频率(IRR 0.96,95%CI 0.69-1.33,P=0.80)培训前后无显著差异。
- 独自用药时间比例培训前后无显著变化(IRR 1.04,95%CI 0.86-1.26,P=0.67)。
- 作者认为,不应因担心风险补偿而拒绝提供THN培训,并需倡导THN的可及性和使用。
适用人群与场景
- 澳大利亚维多利亚州墨尔本及周边地区、2008至2021年纳入SuperMIX队列的成人,基线访谈前6个月内定期注射海洛因或甲基苯丙胺。
- 当前分析仅纳入报告接受过THN培训且培训前至少完成1次访谈的注射吸毒者。
研究设计与关键结果
- 研究类型:队列研究,使用SuperMIX队列2008至2021年前瞻性收集的自我报告行为数据。
- 样本量:SuperMIX队列1328人完成基线访谈(平均[SD]年龄32.4[9.0]岁;男性893人[67.2%]);965人于2017年或之后完成基线或随访访谈,其中390人(40.4%)报告接受过THN培训;最终分析纳入189名有培训前注射频率数据的注射吸毒者(研究期间平均[SD]访谈次数6.2[2.2]次)。
- 暴露:2017年起SuperMIX基线或随访调查开始询问是否及何时接受THN培训;首次记录的THN培训日期作为暴露变量,后续访谈数据排除。
- 主要终点:注射频率(作为过量风险指标)。固定效应回归校正协变量后,培训前后注射频率无变化(IRR 0.91;95%CI 0.69-1.20;P=0.51)。
- 次要终点:阿片类注射频率(IRR 0.95;95%CI 0.74-1.23;P=0.71)、苯二氮䓬类使用频率(IRR 0.96;95%CI 0.69-1.33;P=0.80)、独自用药时间比例(IRR 1.04;95%CI 0.86-1.26;P=0.67)培训前后均无显著变化。
- 协变量:住房状况、收入、研究时间、近期阿片类过量、近期药物治疗、针具和注射器覆盖。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,THN培训不应因担心风险补偿而被拒绝提供。
- 作者认为,需要倡导THN的可及性和使用,以应对前所未有的阿片类相关死亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Concerns that take-home naloxone (THN) training may lead to riskier drug use (as a form of overdose risk compensation) remain a substantial barrier to training implementation. However, there was limited good-quality evidence in a systematic review of the association between THN access and subsequent risk compensation behaviors.
OBJECTIVE: To assess whether THN training is associated with changes in overdose risk behaviors, indexed through injecting frequency, in a cohort of people who inject drugs.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used prospectively collected self-reported behavioral data before and after THN training of participants in The Melbourne Injecting Drug User Cohort Study (SuperMIX). Annual interviews were conducted in and around Melbourne, Victoria, Australia, from 2008 to 2021. SuperMIX participants were adults who regularly injected heroin or methamphetamine in the 6 months preceding their baseline interview. The current study included only people who inject drugs who reported THN training and had participated in at least 1 interview before THN training.
EXPOSURE: In 2017, the SuperMIX baseline or follow-up survey began asking participants if and when they had received THN training. The first THN training date that was recorded was included as the exposure variable. Subsequent participant interviews were excluded from analysis.
MAIN OUTCOMES AND MEASURES: Injecting frequency was the primary outcome and was used as an indicator of overdose risk. Secondary outcomes were opioid injecting frequency, benzodiazepine use frequency, and the proportion of the time drugs were used alone. Fixed-effects generalized linear (Poisson) multilevel modeling was used to estimate the association between THN training and the primary and secondary outcomes. Time-varying covariates included housing status, income, time in study, recent opioid overdose, recent drug treatment, and needle and syringe coverage. Findings were expressed as incidence rate ratios (IRRs) with 95% CIs.
RESULTS: There were 1328 participants (mean [SD] age, 32.4 [9.0] years; 893 men [67.2%]) who completed a baseline interview in the SuperMIX cohort, and 965 participants completed either a baseline or follow-up interview in or after 2017. Of these 965 participants, 390 (40.4%) reported THN training. A total of 189 people who inject drugs had pretraining participant interviews with data on injecting frequency and were included in the final analysis (mean [SD] number of interviews over the study period, 6.2 [2.2]). In fixed-effects regression analyses adjusted for covariates, there was no change in the frequency of injecting (IRR, 0.91; 95% CI, 0.69-1.20; P = .51), opioid injecting (IRR, 0.95; 95% CI, 0.74-1.23; P = .71), benzodiazepine use (IRR, 0.96; 95% CI, 0.69-1.33; P = .80), or the proportion of reported time of using drugs alone (IRR, 1.04; 95% CI, 0.86-1.26; P = .67) before and after THN training.
CONCLUSIONS AND RELEVANCE: This cohort study of people who inject drugs found no evidence of an increase in injecting frequency, along with other markers of overdose risk, after THN training and supply. The findings suggest that THN training should not be withheld because of concerns about risk compensation and that advocacy for availability and uptake of THN is required to address unprecedented opioid-associated mortality.
参考来源
- Colledge-Frisby S, Rathnayake K, Nielsen S, et al. Injection Drug Use Frequency Before and After Take-Home Naloxone Training. JAMA Netw Open. 2023. PMID: 37540514. doi:10.1001/jamanetworkopen.2023.27319
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。